Mode-Dependent Effect of Xenon Inhalation on Kainic Acid-Induced Status Epilepticus in Rats.

kainic acid neuronal injury seizure status epilepticus xenon

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2019
Historique:
received: 25 04 2019
accepted: 30 07 2019
entrez: 3 9 2019
pubmed: 3 9 2019
medline: 3 9 2019
Statut: epublish

Résumé

Previous studies have reported the possible neuroprotective effects of xenon treatment. The purpose of this study was to define the range of effective xenon ratio, most effective xenon ratio, and time-window for intervention in the kainic acid (KA) - induced status epilepticus (SE) rat model. Different ratios of xenon (35% xenon, 21% oxygen, 44% nitrogen, 50% xenon, 21% oxygen, 29% nitrogen, 70% xenon, 21% oxygen, and 9% nitrogen) were used to treat the KA-induced SE. Our results confirmed the anti-seizure role of 50 and 70% xenon mixture, with a stronger effect from the latter. Further, 70% xenon mixture was dispensed at three time points (0 min, 15 min delayed, and 30 min delayed) after KA administration, and the results indicated the anti-seizure effect at all treated time points. The results also established that the neuronal injury in the hippocampus and entorhinal cortex (EC), assessed using Fluoro-Jade B (FJB) staining, were reversed by the xenon inhalation, and within 30 min after KA administration. Our study, therefore, indicates the appropriate effective xenon ratio and time-window for intervention that can depress seizures. The prevention of neuronal injury and further reversal of the loss of effective control of depress network in the hippocampus and EC may be the mechanisms underlying the anti-seizure effect of xenon.

Identifiants

pubmed: 31474835
doi: 10.3389/fncel.2019.00375
pmc: PMC6702968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

375

Références

Neurology. 2000 Feb 8;54(3):776
pubmed: 10680833
N Engl J Med. 2001 Aug 2;345(5):311-8
pubmed: 11484687
Mayo Clin Proc. 2003 Feb;78(2):238-48
pubmed: 12583536
J Neurosurg. 2003 Sep;99(3):500-3
pubmed: 12959437
Epilepsy Res Suppl. 1992;7:273-80
pubmed: 1334666
J Comp Neurol. 1956 Oct;105(3):417-537
pubmed: 13385382
Lancet Neurol. 2004 Feb;3(2):111-8
pubmed: 14747003
Brain. 2004 Sep;127(Pt 9):2018-30
pubmed: 15215219
Neurobiol Dis. 2005 Jun-Jul;19(1-2):119-28
pubmed: 15837567
Epilepsia. 2005 Jun;46(6):858-77
pubmed: 15946327
Stroke. 2006 Feb;37(2):501-6
pubmed: 16373643
Neurobiol Dis. 2006 Aug;23(2):312-28
pubmed: 16815026
Prog Brain Res. 2007;163:601-13
pubmed: 17765740
Neurobiol Dis. 2008 Jan;29(1):52-8
pubmed: 17904855
Neurobiol Dis. 2008 Jul;31(1):74-9
pubmed: 18499467
Anesthesiology. 2008 Nov;109(5):782-9
pubmed: 18946288
Ann Neurol. 2008 Dec;64(6):674-86
pubmed: 19107991
Epilepsia. 2010 Sep;51(9):1861-4
pubmed: 20662893
Minerva Anestesiol. 2011 Jun;77(6):571-8
pubmed: 21617619
Neuroscience. 2012 Jul 12;214:149-58
pubmed: 22531374
PLoS One. 2012;7(5):e37020
pubmed: 22615878
Arch Dis Child Fetal Neonatal Ed. 2013 Sep;98(5):F437-9
pubmed: 23572341
PLoS One. 2013 Jun 18;8(6):e66885
pubmed: 23825580
Br J Anaesth. 2014 Jul;113(1):168-76
pubmed: 24277726
Brain Inj. 2014;28(3):364-9
pubmed: 24377428
Exp Neurol. 2016 Feb;276:22-30
pubmed: 26621617
Trends Neurosci. 2016 Apr;39(4):235-245
pubmed: 26874794
Pharmacol Ther. 2016 Apr;160:159-79
pubmed: 26899498
Neuroreport. 2016 May 4;27(7):501-7
pubmed: 26999361
Cell Death Dis. 2016 Apr 07;7:e2182
pubmed: 27054337
Exp Neurol. 2017 Jan;287(Pt 1):65-74
pubmed: 27527984
Brain Stimul. 2016 Nov - Dec;9(6):933-939
pubmed: 27553886
Sci Rep. 2016 Sep 26;6:33943
pubmed: 27666871
Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):61-68
pubmed: 27695956
Front Cell Neurosci. 2017 May 31;11:149
pubmed: 28620281
JAMA Neurol. 2018 Mar 1;75(3):279-286
pubmed: 29279892
Br J Surg. 2018 Jul;105(8):1051-1060
pubmed: 29603122
Front Cell Neurosci. 2018 May 29;12:147
pubmed: 29896092
Epilepsia. 2018 Sep;59(9):1774-1784
pubmed: 30039519
Front Cell Neurosci. 2018 Sep 05;12:301
pubmed: 30233331
Neurobiol Dis. 2019 Jan;121:177-186
pubmed: 30304705
Epilepsia. 2018 Nov;59(11):2019-2034
pubmed: 30338519
Redox Biol. 2019 Jan;20:195-203
pubmed: 30368039
Front Cell Neurosci. 2018 Oct 01;12:302
pubmed: 30386206
Nat Neurosci. 2018 Dec;21(12):1742-1752
pubmed: 30482946
Acta Neurol Belg. 2019 Jun;119(2):163-173
pubmed: 30953298
Front Cell Neurosci. 2019 Mar 29;13:123
pubmed: 30983975
Brain Res Bull. 2019 Jul;149:106-119
pubmed: 31005663
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
pubmed: 4110397
Lancet. 1993 Jun 26;341(8861):1607-10
pubmed: 8099987
J Neurosci. 1997 Dec 1;17(23):9308-14
pubmed: 9364076

Auteurs

Yurong Zhang (Y)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Mengdi Zhang (M)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Jie Yu (J)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Wei Zhu (W)

Shandong Academy of Medical Sciences, Jinan, China.

Qiaoyun Wang (Q)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Xiaohong Pan (X)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Xue Gao (X)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Jing Yang (J)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Hongliu Sun (H)

School of Pharmaceutical Sciences, Binzhou Medical University, Yantai, China.

Classifications MeSH